J&J's $3.05B move for Halda adds targeted oral cancer therapies and expands its prostate cancer pipeline amid rising pharma M&A.

"Most ulcers are nothing to worry about," Dr Bozic added. "But if one refuses to heal, don't wait. Getting it checked could ...

Persistent sores can occasionally indicate early oral or throat cancer, especially in those who smoke, drink frequently, or ...

Heartburn, a common ailment, can sometimes signal Gastroesophageal Reflux Disease (GERD). While GERD is manageable, ...

Early cancer detection in India hinges on recognising subtle symptoms often overlooked. Oncologist Dr. Jayesh Sharma ...

You should consult a doctor if you notice any of four "persistent" symptoms that "won't go away". According to experts, ...

You should consult a doctor if you notice any of four "persistent" symptoms that "won't go away". According to experts, ...

UCR Health pediatrician explains symptoms, transmission, and what parents should watch for as outbreaks spread ...

Halda Therapeutics is developing oral assets for prostate and lung cancer. The deal comes after Johnson & Johnson set an ...

Johnson & Johnson has added to the flurry of M&A deals in pharma with an agreement to buy US biotech Halda Therapeutics and ...

Oral health is often underestimated until discomfort strikes. Yet, the strength of a community’s overall well-being is ...